Lilly Hires External Adviser for COVID-19 Drug Plant Problems Lilly Hires External Adviser for COVID-19 Drug Plant Problems

Eli Lilly and Co said late on Tuesday it had hired an independent consultant to review a plant producing its COVID-19 antibody drug after receiving a notice from the U.S. health regulator.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news
More News: COVID-19 | Pathology